Correction: The spectrum of TP53 mutations in Rwandan patients with gastric cancer

Affiliations

• ¹ Department of Tumor Pathology, Hamamatsu University School of Medicine (HUSM), 1-20-1 Handayama, Higashi-Ku, 431-3192, Hamamatsu, Shizuoka, Japan.
• ² Department of Biomedical Laboratory Sciences, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, P.O. Box 3286, Rwanda.
• ³ Department of Pathology, University Teaching Hospital of Kigali, Kigali, P.O. Box 655, Rwanda.
• ⁴ Université Catholique de Louvain, Médecine Expérimentale, 1348, Brussels, Belgium.
• ⁵ Department of Pharmacology, Sahlgrenska Academy, University of Gothenburg, SE-40530, Gothenburg, Sweden.
• ⁶ Department of Pathology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, P.O. Box 3286, Rwanda.
• ⁷ Department of Internal Medicine, University Teaching Hospital of Kigali, Kigali, P.O. Box 655, Rwanda.
• ⁸ Department of Health Policy and Management, Keio University School of Medicine, 160-8582, Tokyo, Japan.
• ⁹ Department of Tumor Pathology, Hamamatsu University School of Medicine (HUSM), 1-20-1 Handayama, Higashi-Ku, 431-3192, Hamamatsu, Shizuoka, Japan. [email protected].
• ¹⁰ Sasaki Institute Sasaki Foundation, 2-2 Kanda Surugadai, Chiyoda-Ku, 101-0062, Tokyo, Japan. [email protected].
• ¹¹ Department of Tumor Pathology, Hamamatsu University School of Medicine (HUSM), 1-20-1 Handayama, Higashi-Ku, 431-3192, Hamamatsu, Shizuoka, Japan. [email protected].